ZA989207B - Method of building and maintaining bone. - Google Patents

Method of building and maintaining bone.

Info

Publication number
ZA989207B
ZA989207B ZA9809207A ZA989207A ZA989207B ZA 989207 B ZA989207 B ZA 989207B ZA 9809207 A ZA9809207 A ZA 9809207A ZA 989207 A ZA989207 A ZA 989207A ZA 989207 B ZA989207 B ZA 989207B
Authority
ZA
South Africa
Prior art keywords
building
maintaining bone
bone
maintaining
Prior art date
Application number
ZA9809207A
Other languages
English (en)
Inventor
Masahiko Sato
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA989207B publication Critical patent/ZA989207B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
ZA9809207A 1997-10-14 1998-10-08 Method of building and maintaining bone. ZA989207B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6180097P 1997-10-14 1997-10-14

Publications (1)

Publication Number Publication Date
ZA989207B true ZA989207B (en) 2000-04-10

Family

ID=22038230

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9809207A ZA989207B (en) 1997-10-14 1998-10-08 Method of building and maintaining bone.

Country Status (7)

Country Link
US (1) US20020025929A1 (fr)
EP (1) EP1030658A1 (fr)
JP (1) JP2001519384A (fr)
AU (1) AU9682098A (fr)
CA (1) CA2306344A1 (fr)
WO (1) WO1999018945A1 (fr)
ZA (1) ZA989207B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6417333B1 (en) 1998-11-25 2002-07-09 The General Hospital Corporation Modified human parathyroid hormone
US7169567B1 (en) 1998-12-31 2007-01-30 The General Hospital Corporation Screening assay utilizing the PTH receptor
US7820393B2 (en) * 1999-01-14 2010-10-26 Scantibodies Laboratory, Inc. Methods, kits and antibodies for detecting parathyroid hormone
US6689566B1 (en) 1999-01-14 2004-02-10 Scantibodies Laboratory, Inc. Methods, kits, and antibodies for detecting parathyroid hormone
WO2003032957A2 (fr) * 2001-06-28 2003-04-24 Microchips, Inc. Procede de fermeture hermetique de dispositifs a puits contenant des microplaquettes
US7572765B2 (en) 2001-07-23 2009-08-11 The General Hospital Corporation Conformationally constrained parathyroid hormone (PTH) analogs
WO2004022033A1 (fr) * 2002-09-04 2004-03-18 Microchips, Inc. Technique et dispositif d'apport commande d'hormone parathyroide
US8088734B2 (en) 2003-01-21 2012-01-03 Unigene Laboratories Inc. Oral delivery of peptides
MXPA06013168A (es) 2004-05-13 2007-05-15 Johnson & Johnson Aparato y metodo para el suministro transdermico de agentes de la hormona paratiroidea.
AU2006208131A1 (en) * 2005-01-25 2006-08-03 Microchips, Inc. Control of drug release by transient modification of local microenvironments
WO2007059470A2 (fr) * 2005-11-10 2007-05-24 Board Of Control Of Michigan Technological University Parathormone de l'ours noir et procedes d'utilisation de la parathormone de l'ours noir
SI2084183T1 (sl) * 2006-10-13 2010-09-30 Lilly Co Eli Pegilirani pth kot modulatorji pth receptorja in njihove uporabe
BRPI0814962B8 (pt) 2007-08-01 2021-05-25 Chugai Pharmaceutical Co Ltd métodos in vitro para determinar se um composto candidato é um agonista de longa duração ou de curta duração de um receptor acoplado à proteína g, polipeptídeo, seu uso e composição farmacêutica
WO2011071480A1 (fr) 2009-12-07 2011-06-16 Michigan Technological University Hormone parathyroïde de l'ours noir et ses procédés d'utilisation
CN103002906B (zh) 2010-05-13 2017-12-29 总医院有限公司 甲状旁腺激素类似物及其应用
EP3016674A4 (fr) 2013-06-23 2017-03-15 Wisconsin Alumni Research Foundation Analogues polypeptidiques alpha ou bêta de la parathormone (pth) et méthode d'utilisation associée
WO2016065052A1 (fr) 2014-10-22 2016-04-28 Extend Biosciences, Inc. Conjugués insuline vitamine d
US9585934B2 (en) * 2014-10-22 2017-03-07 Extend Biosciences, Inc. Therapeutic vitamin D conjugates
CN108025042A (zh) * 2015-07-06 2018-05-11 董正欣 PTHrP类似物的新型制剂
KR20210038618A (ko) * 2018-07-30 2021-04-07 샤이어-엔피에스 파마슈티칼즈, 인크. 재조합 인간 부갑상선 호르몬의 개선된 안정성을 위한 제형

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605815A (en) * 1988-03-14 1997-02-25 Yale University Nucleic acids encoding and expression of parathyroid hormone-like peptide
US5118667A (en) * 1991-05-03 1992-06-02 Celtrix Pharmaceuticals, Inc. Bone growth factors and inhibitors of bone resorption for promoting bone formation
US5317010A (en) * 1991-10-10 1994-05-31 Peter K. T. Pang Parathyroid hormone analogues substituted at AA 25, 26, 27, and use in osteoporosis treatment
TW303299B (fr) * 1993-07-22 1997-04-21 Lilly Co Eli
US5510357A (en) * 1995-02-28 1996-04-23 Eli Lilly And Company Benzothiophene compounds as anti-estrogenic agents

Also Published As

Publication number Publication date
CA2306344A1 (fr) 1999-04-22
AU9682098A (en) 1999-05-03
JP2001519384A (ja) 2001-10-23
EP1030658A1 (fr) 2000-08-30
US20020025929A1 (en) 2002-02-28
WO1999018945A1 (fr) 1999-04-22

Similar Documents

Publication Publication Date Title
AP2000001783A0 (en) Disinfectant and method of making
IL135261A (en) Footwear and its method of construction
GB2311192B (en) Data-transmitter-receiver and method of operation
ZA989399B (en) Method and composition
AU2389600A (en) Reservoir-and-filter system and method of use
AP2001002080A0 (en) Pilveriser and method of pulverising
AU9682098A (en) Method of building and maintaining bone
GB2346823B (en) Reamer and method of using the same
GB2330478B (en) Receiver and method of construction
PL335074A1 (en) Method of obtaining eprosartane
GB9706070D0 (en) Method of decomposing polychlorodibenzo-p-dioxins and/or polychlorodibenzofurans
PL335075A1 (en) Method of obtaining eprosartane
PL325142A1 (en) Novel compounds-derivatives of benzoxazinodione, method of obtaining them and their application
PL336266A1 (en) Method of obtaining epsilon-caprolactams
GB9620556D0 (en) Door and method of construction
GB9620555D0 (en) Door and method of construction
PL324971A1 (en) Amidopropylo-n-alkyl polyhydroxyalkylamine compounds, method of obtaining them and their application
PL340497A1 (en) Method of obtaining formylimidazoles
PL325306A1 (en) Epoxyazetidiones, method of obtaining them and their application
PL327389A1 (en) Novel seco-compounds of thylosine class and method of obtaining them
PL341763A1 (en) Triazepinones, method of obtaining them and their therapeutic application
ZA9811960B (en) Salicylaldoximes and method of preparation.
PL342185A1 (en) Modified psilium and method of obtaining same
PL326573A1 (en) Novel paragene and method of obtaining same
PL317586A1 (en) Amidopropylo-n-alkyl polyhydroxyalkylamine compounds, method of obtaining them and their application